Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**(+)-Menthol** is a stereoisomer of menthol belonging to the class of menthane monoterpenoids. It is a naturally occurring organic compound found in mint oils and can also be synthesized. While the more common form used medicinally is (-)-menthol (levomenthol), (+)-menthol shares similar physical and chemical properties. Menthol acts primarily as a topical analgesic and counterirritant by activating cold-sensitive Transient receptor potential cation channel subfamily M member 8 (TRPM8) receptors in sensory neurons. This activation produces a cooling sensation and provides relief from minor pain or irritation by modulating neuronal calcium influx and desensitizing pain pathways[7][8][6]. Additional mechanisms may include weak agonism at Kappa-type opioid receptor and modulation of other ion channels such as Voltage-dependent L-type calcium channel[2][6]. The primary indications for menthol compounds are temporary relief of minor aches/pains in muscles/joints or soothing effects on sore throat/irritated mucosa.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (+)-Menthol.